Skip to main content
NHCNational HealthCare CorporationSell4.5·$194.93-1.41%
Open full analysis

National HealthCare Corporation (NHC) Stock Analysis

Breakout setup

SellVALUE-TRAP 1/5High Confidence

Healthcare · Medical Care Facilities

Sell if holding. Multiple concerning factors at $194.93: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (4.9% away).

National HealthCare Corporation operates skilled nursing facilities, assisted living, independent living, homecare/hospice, and behavioral health services across 9 states, primarily in the Southeast and Midwest. In fiscal 2025, 96.8% of net operating revenues came from... Read more

$194.93+3.1% A.UpsideScore 4.5/10#27 of 27 Medical Care Facilities
QualityF-score8 / 9FCF yield3.84%
IncomeYield1.31%(5y avg 2.75%)Payout32.53%sustainable
Stop $182.67Target $200.96(resistance)A.R:R 0.0:1

Sell if holding. Multiple concerning factors at $194.93: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (4.9% away). Chart setup: Golden cross, above all MAs, RSI 55, MACD bullish. Score 4.5/10, high confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202652d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Earnings expected to decline ~95% (cyclical peak)
Near 52-week high (4.9% away)
Leverage penalty (D/E 3.6): -1.5

Key Metrics

P/E (TTM)25.1
P/E (Fwd)459.8
Mkt Cap$3.1B
EV/EBITDA16.4
Profit Mgn8.1%
ROE12.0%
Rev Growth2.2%
Beta0.67
Dividend1.31%
Rating analysts

Quality Signals

Piotroski F8/9

Options Flow

P/C0.46bullish
IV57%elevated
Max Pain$140-28.2% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
1.5
Growth Rank
1.5
Quality Rank
5.8

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Earnings Timing
5.0
Dividend Safety
5.2
Earnings concerns: 0B/4MDividend: 131.0%

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.0
Earnings Growth
3.9
GatesMomentum 5.2<5.5 (soft — BUY_NOW allowed but watch)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Momentum 5.2>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 52d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
55 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $176.75Resistance $205.06

Price Targets

$183
$201
A.Upside+3.1%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Cyclical trap - fwd PE 460x vs trail 25x (18.3x)

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-06 (52d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NHC stock a buy right now?

Sell if holding. Multiple concerning factors at $194.93: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (4.9% away). Chart setup: Golden cross, above all MAs, RSI 55, MACD bullish. Prior stop was $182.67. Score 4.5/10, high confidence.

What is the NHC stock price target?

Take-profit target: $200.96 (+3.1% upside). Prior stop was $182.67. Stop-loss: $182.67.

What are the risks of investing in NHC?

Earnings expected to decline ~95% (cyclical peak); Near 52-week high (4.9% away); Leverage penalty (D/E 3.6): -1.5.

Is NHC overvalued or undervalued?

National HealthCare Corporation trades at a P/E of 25.1 (forward 459.8). TrendMatrix value score: 5.3/10. Verdict: Sell.

0
What does National HealthCare Corporation do?National HealthCare Corporation operates skilled nursing facilities, assisted living, independent living,...

National HealthCare Corporation operates skilled nursing facilities, assisted living, independent living, homecare/hospice, and behavioral health services across 9 states, primarily in the Southeast and Midwest. In fiscal 2025, 96.8% of net operating revenues came from healthcare services; Medicare provided 31% and Medicaid 30% of net patient revenues. The company is purchasing 32 skilled nursing and 3 independent living facilities from NHI for $560M, resolving a disputed Master Lease.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · UHS (Universal Health Services, Inc.) · ASTH (Astrana Health Inc.) · ARDT (Ardent Health, Inc.)
Home Stocks NHC

Latest news

Latest News

Yahoo Finance41d ago
Markets Mojo42d agoAnalyst
MarketBeat47d ago
Geneonline.com39d ago
Stock Titan39d ago
Insider Monkey43d ago
MarketBeat38d ago
MarketBeat39d ago
GuruFocus39d ago
Kare11.com39d agoEarnings
Kens5.com39d agoEarnings
KING5.com39d agoEarnings
WKYC39d agoEarnings
Marketscreener.com39d agoEarnings
GuruFocus39d ago
MarketBeat39d ago
MarketBeat39d ago
Stock Titan45d ago
Benzinga11d agoLeadership Change
Benzinga31d ago
Loading more...